1999
DOI: 10.1093/jac/43.6.829
|View full text |Cite
|
Sign up to set email alerts
|

Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin

Abstract: Escherichia coli isolate 16,906 expressing lux genes was used for real-time monitoring of moxifloxacin effects on bacterial metabolism compared with effects on cell replication. Viable counts showed concentration-dependent killing by moxifloxacin; real-time measurement of bioluminescence on the same cultures showed metabolic activity over 54 h, but with greater inhibition at 1 x MIC than with higher MIC multiples. Post-antibiotic effect was longer when determined using bioluminescence than by viable counts. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(28 citation statements)
references
References 8 publications
0
28
0
Order By: Relevance
“…As the production of bioluminescence from recombinant bacteria containing the lux genes depends on biochemically active bacterial cells, it can be assumed that any compound that impairs the biochemistry and thus compromises cellular viability leads to a rapid reduction in luminescence. The effects of antimicrobial compounds on lux-containing recombinant bacteria can therefore be readily assessed (36,37,39,41,46). Figure 1C shows that the growth-dependent bioluminescence of S. aureus RN6390(pSB2030) was completely inhibited by 10 M 3-oxo-C 12 -HSL.…”
Section: Resultsmentioning
confidence: 99%
“…As the production of bioluminescence from recombinant bacteria containing the lux genes depends on biochemically active bacterial cells, it can be assumed that any compound that impairs the biochemistry and thus compromises cellular viability leads to a rapid reduction in luminescence. The effects of antimicrobial compounds on lux-containing recombinant bacteria can therefore be readily assessed (36,37,39,41,46). Figure 1C shows that the growth-dependent bioluminescence of S. aureus RN6390(pSB2030) was completely inhibited by 10 M 3-oxo-C 12 -HSL.…”
Section: Resultsmentioning
confidence: 99%
“…By this methodology we have demonstrated that not only antibacterial properties but also the course and the relapse of the infection can be monitored optically in vivo in real time in living animals. In addition, the approach resulted in a considerable savings in Bioluminescent bacteria have previously been used successfully for the measurement of antibacterial activity in vitro (14,22,33,36,38,40,41) and for the measurement of activity against acute in vivo infections (5,6,10,11,16,34). The model presented here permits for the first time longitudinal monitoring of chronic biofilm infections and the response to therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Measurements of optical density are often used to assess antibiotic efficacy and pharmacokinetics prior to testing in mouse models. Bacteria expressing bioluminescent [9,10], or fluorescent [11,12] genetic reporters have been incorporated in these basic in vitro systems as a way of enhancing the sensitivity of the toxicity assays. More sophisticated in vitro models of infection employ a mixed culture of mammalian and bacteria cells.…”
Section: Imaging In Vitro Models Of Bacterial Infectionmentioning
confidence: 99%